Modified Islet Cell Transplantation Leads to Insulin Independence in Patients With Type 1 Diabetes
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Modified Islet Cell Transplantation Leads to Insulin Independence in Patients With Type 1 Diabetes

NEW YORK -- June 11, 2008 -- Researchers have modified the procedure for islet cell transplantation and achieved insulin independence with fewer, but better functioning pancreatic islet cells in patients with diabetes. The study results are published in the June issue of the American Journal of Transplantation.

The new procedure allowed patients to achieve insulin independence after a single transplant versus the 2 to 4 transplants that were needed using the older protocol, said lead author José Oberholzer, MD, University of Illinois at Chicago (UIC), Chicago, Illinois.

In the study, patients with type 1 diabetes (N = 10) received between 1 and 3 islet cell transplants and were followed for 15 months. Patients in group 1 (n = 4) received the Edmonton protocol, which uses a combination of 2 immunosuppressants and a monoclonal antibody drug, daclizumab. Patients in group 2 (n = 6) received the UIC protocol -- a combination of etanercept and exenatide -- and the Edmonton regimen.

All patients in the study achieved insulin independence, but patients in group 2 required fewer than half the number of islets as those in group 1. Patients in group 1 needed either 2 or 3 sequential islet cell transplants to achieve insulin independence, whereas patients in group 2 initially achieved insulin independence after only 1 islet transplant. Two of the patients in group 2 required a second islet cell transplant, and 1 resumed insulin 5 months after the second transplant due to other complications.

According to Dr. Oberholzer, progress in islet cell transplantation has been limited by the shortage of donor organs.

"This study is extremely promising and shows that we can achieve success with fewer islet cells, freeing patients from the need to check their insulin, even after 20 or 30 years of suffering from diabetes," he added.

SOURCE: University of Illinois at Chicago

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities